Evidence map›Paper›PMID 31277667›Full record

ArticleJournal of nanobiotechnology2019

Photothermal and gene therapy combined with immunotherapy to gastric cancer by the gold nanoshell-based system.

Jiayu Zhang, Tiancheng Zhao, Fanglei Han, Yu Hu, Yezhou Li

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. [Hyperthermia on colorectal cancer: gold nanoshells-mediated photothermal therapy].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jiayu ZhangDepartment of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, No. 126 XianTai Street, Changchun, 130033, Jilin, China.
Tiancheng ZhaoDepartment of Endoscopic Center, China-Japan Union Hospital of Jilin University, No. 126 XianTai Street, Changchun, 130033, Jilin, China.
Fanglei HanDepartment of Anesthesiology, China-Japan Union Hospital of Jilin University, No. 126 XianTai Street, Changchun, 130033, Jilin, China.
Yu HuPathology Department, China-Japan Union Hospital of Jilin University, No. 126 XianTai Street, Changchun, 130033, Jilin, China. 68564908@qq.com.
Yezhou LiDepartment of Vascular Surgery, China-Japan Union Hospital of Jilin University, No. 126 XianTai Street, Changchun, 130033, Jilin, China. yzsubmission@163.com.
Jilin University · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe gastric cancer is the second most malignant tumor in the world. HER-2 is one of the key targets for the gastric cancer therapy. Anti-HER-2 antibodies like trastuzumab, exhibits the satisfactory therapeutic effect in clinical. However, the drug resistance problem limits its application.

methodIn this study, we develop a gold nanoshell (Gold Nanoshell) drug carrier for delivery and selective photo-thermal release of genes which target HER-2 and immunologic adjuvant CPG sequence in gastric tumor cells. The drug delivery system generated a multidimensional treatment strategy which includes gene-, immune- and photothermal-therapy.

resultsThe whole gold nanoshell drug delivery system exhibits the well gene transduction ability and combined treatment effect. Both in vitro and in vivo results demonstrate the multiple therapeutic effects of the drug delivery system is better than the monotherapy.

conclusionsThis study indicates the multiple combined therapy based on the gold nanoshell system would be a promising translational treatment for gastric cancer.

Indexed as

AnimalsApoptosisCell Line, TumorCell SurvivalCombined Modality TherapyErb-b2 Receptor Tyrosine KinasesGenetic TherapyGoldHumansHyperthermia, InducedImmunotherapyMice, NudeMolecular Targeted TherapyNanoshellsPhototherapyStomach NeoplasmsERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesGold

Identifiers

PMID31277667
PMCPMC6612092
OpenAlexW2953609997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.